Inbec 30 mg (Abacavir/Dolutegravir/Lamivudine)
| Active Ingredient | Abacavir/Dolutegravir/Lamivudine |
|---|---|
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Indication: | HIV infection |
| Packaging | 30 Tablets in bottle |
| Strength | 30mg |
| Delivery Time | 6 To 15 days |
Inbec 30 mg is a once-daily fixed-dose combination antiretroviral tablet containing Abacavir, Dolutegravir, and Lamivudine. It is used in the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg. This single-tablet regimen simplifies HIV management by combining three powerful agents with complementary actions that reduce viral replication and improve immune function.
Key Ingredients & Their Functions:
Dolutegravir (30 mg): An integrase strand transfer inhibitor (INSTI) that blocks the integration of viral DNA into host DNA.
Abacavir (600 mg): A nucleoside reverse transcriptase inhibitor (NRTI) that stops the reverse transcription of viral RNA into DNA.
Lamivudine (300 mg): Another NRTI that also targets the reverse transcriptase enzyme to prevent viral replication.








There are no reviews yet.